NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.42% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.29% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.14% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 2.08% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.02% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 1.99% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 1.99% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 1.96% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 1.94% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 1.93% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 1.93% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.91% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 1.88% |
| ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 1.82% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 1.81% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.81% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 1.80% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.78% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.77% |